References:
1.Herrmann W, Obeid R. Homocysteine: a biomarker in neurodegenerative diseases. Clin Chem Lab Med. 2011 Mar;49(3):435-41. http://www.ncbi.nlm.nih.gov/pubmed/21388339
2.Saposnik G, Ray JG, Sheridan P, McQueen M, et al. Heart Outcomes Prevention Evaluation 2 Investigators. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke. 2009 Apr;40(4):1365-72. http://www.ncbi.nlm.nih.gov/pubmed/19228852
3.Herrmann W, Obeid R. Homocysteine: a biomarker in neurodegenerative diseases. Clin Chem Lab Med. 2011 Mar;49(3):435-41. https://www.seekinghealth.com/media/Homocysteine%20Biomarker%20Neurodegenerative%20Diseases.pdf